APC clinical trials at UCSF

1 research study open to eligible people

APC is a gene that helps control cell growth. UCSF is studying an investigational drug in adults with advanced solid tumors to learn about safety and tumor effects. UCSF is recording medical tests and imaging results.

FOG-001 in Locally Advanced or Metastatic Solid Tumors
open to eligible people ages 18 years and up
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic cancer.
San Francisco, California and other locations

Last updated: January 8, 2026